MARKET

TLX

TLX

Telix Pharmaceuticals Ltd ADR
NASDAQ
11.53
+0.23
+2.04%
Closed 19:47 06/30 EDT
OPEN
11.30
PREV CLOSE
11.30
HIGH
11.58
LOW
11.30
VOLUME
183.43K
TURNOVER
--
52 WEEK HIGH
16.98
52 WEEK LOW
6.28
MARKET CAP
3.91B
P/E (TTM)
-546.4455
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at TLX last week (0622-0626)?
Weekly Report · 1d ago
Telix Educational Webinar: Neuro-Oncology Portfolio Update and Physician Perspectives on Future Therapeutic Directions
Barchart · 06/22 16:40
Weekly Report: what happened at TLX last week (0615-0619)?
Weekly Report · 06/22 10:37
Gubra appoints Lena Moran-Adams group general counsel
PUBT · 06/16 05:31
Weekly Report: what happened at TLX last week (0608-0612)?
Weekly Report · 06/15 10:37
Weekly Report: what happened at TLX last week (0601-0605)?
Weekly Report · 06/08 10:32
Telix Pharmaceuticals Signs MoU With United Imaging Healthcare North America To Evaluate A U.S. Research Collaboration On Advancing Integrated Theranostics Solutions
Benzinga · 06/02 11:17
Telix signs MOU with United Imaging to evaluate U.S. theranostics collaboration
PUBT · 06/02 11:02
More
About TLX
Telix Pharmaceuticals Limited is an Australia-based biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. Its segments include Therapeutics, Precision Medicine and Telix Manufacturing Solutions. Therapeutics segment develops targeted radionuclide therapies for urologic, neurologic, musculoskeletal and hematological cancers. Precision Medicine segment focuses on bringing diagnostic imaging solutions to market. Precision Medicine segment also includes MedTech and International businesses. Telix Manufacturing Solutions segment is its global network of facilities designed to deliver patient doses worldwide. Its pipeline products include TLX591, TLX250, TLX101, TLX66, TLX592, TLX252, TLX400, Illuccix (68Ga-PSMA-11) and TLX007-CDx.

Webull offers Telix Pharmaceuticals Ltd stock information, including NASDAQ: TLX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TLX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TLX stock methods without spending real money on the virtual paper trading platform.